Strides Pharma Science Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 07, 2025
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science held its 34th AGM on August 7, 2025, via video conference, lasting about 90 minutes. The meeting was chaired by Founder and Non-Executive Chairperson Arun Kumar, with Managing Director and Group CEO Badree Komandur presenting the company's performance for FY25. Shareholders transacted five ordinary resolutions, including adoption of audited financial statements for FY ended March 31, 2025, declaration of a final dividend, and re-appointment of Executive Director Aditya Arun Kumar as a retiring director. The Auditor's Report on consolidated and standalone statements contained no qualifications, observations, or adverse comments. Additionally, M/s V. Sreedharan & Associates was appointed as the new Secretarial Auditor, and remuneration for the Cost Auditors for FY 2025-26 was approved. E-voting results are expected to be declared by August 11, 2025.
This is a routine regulatory disclosure confirming that key annual items — financials, dividend, and director re-appointment — were put to vote at the AGM, with a clean audit report providing comfort to shareholders. The final dividend declaration is the most tangible shareholder benefit, though the exact amount will be confirmed once the e-voting results are announced.